Dimensions in Diabetes Launched in India

The Society launched its new Dimensions in Diabetes program in Chennai, India on Saturday November 20 and Sunday November 21 as part of Diabetes Awareness month activities.

Andrew Ahrman, MD, lights the ceremonial “flame of knowledge” to kick off Diabetes Awareness Month at the launch of Dimensions in Diabetes in Chennai, India.
Andrew Ahmann, MD, lights the ceremonial “flame of knowledge” to kick off Diabetes Awareness Month at the launch of Dimensions in Diabetes in Chennai, India.

Eight Society members contributed to this curriculum that covered the basics of diabetes management like diet, nutrition, and motivational interviewing, managing special patient populations, including pregnant patients and those with hypoglycemia, and emerging areas such as use of new classes of drugs, and leading-edge diabetes technology. The annual program has educational support from Sun Pharmaceuticals.

Serving as the inaugural program faculty were Vice President Clinical Science, Anthony McCall, MD, PhD, Council-elect member, Carol Wysham, MD, Andrew Ahmann, MD, Ian Blumer, MD, Jack Leahy, MD, Janet McGill, MD, MA, Jane Reusch, MD, PhD, and Steven Russell, MD, PhD. Luckily, the terrible monsoon rains paused long enough for our faculty and 370 attendees to travel in and out of Chennai safely.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…